UK markets closed

Alnylam Pharmaceuticals, Inc. (ALNY)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
142.63-1.17 (-0.81%)
As of 11:39AM EDT. Market open.
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
812,688
866,394
819,975
496,580
Other short-term investments
1,626,694
1,326,012
1,615,589
1,377,815
Total cash
2,439,382
2,192,406
2,435,564
1,874,395
Net receivables
327,787
237,963
198,571
102,413
Inventory
89,146
128,962
86,363
75,202
Other current assets
126,382
132,916
88,078
62,767
Total current assets
2,982,697
2,692,247
2,808,576
2,614,777
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
948,865
912,080
874,048
810,861
Accumulated depreciation
-223,076
-173,450
-140,415
-104,347
Net property, plant and equipment
725,789
738,630
733,633
706,514
Other long-term assets
121,394
115,482
101,095
85,770
Total non-current assets
847,183
854,112
834,728
792,284
Total assets
3,829,880
3,546,359
3,643,304
3,407,061
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
55,519
98,094
73,426
51,966
Accrued liabilities
590,843
414,770
301,591
258,476
Deferred revenues
102,753
42,105
149,483
127,207
Other current liabilities
54,991
40,289
37,079
13,316
Total current liabilities
967,786
767,915
695,710
585,270
Non-current liabilities
Long-term debt
1,020,776
1,016,942
675,697
191,278
Deferred revenues
188,175
193,791
152,360
225,094
Other long-term liabilities
1,630,686
1,464,595
1,249,987
1,096,133
Total non-current liabilities
3,082,738
2,936,667
2,359,391
1,805,544
Total liabilities
4,050,524
3,704,582
3,055,101
2,390,814
Stockholders' equity
Common stock
1,259
1,240
1,202
1,164
Retained earnings
-7,009,591
-6,569,349
-5,438,193
-4,585,369
Accumulated other comprehensive income
-23,375
-44,654
-33,259
-43,622
Total stockholders' equity
-220,644
-158,223
588,203
1,016,247
Total liabilities and stockholders' equity
3,829,880
3,546,359
3,643,304
3,407,061